Thermo Fisher Scientific, Inc. Stock
Equities
TMO
US8835561023
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 504.82 USD | -0.98% |
|
-7.67% | -12.88% |
| Capitalization | 190B 160B 146B 139B 259B 17,221B 268B 1,696B 674B 8,290B 711B 697B 29,111B | P/E ratio 2025 |
32.7x | P/E ratio 2026 * | 25.8x |
|---|---|---|---|---|---|
| Enterprise value | 218B 184B 168B 160B 297B 19,789B 308B 1,949B 775B 9,527B 817B 801B 33,452B | EV / Sales 2025 |
5.55x | EV / Sales 2026 * | 4.6x |
| Free-Float |
86.06% | Yield 2025 * |
0.33% | Yield 2026 * | 0.36% |
Last Transcript: Thermo Fisher Scientific, Inc.
| 1 day | -0.98% | ||
| 1 week | -7.67% | ||
| Current month | -12.75% | ||
| 1 month | -18.41% | ||
| 3 months | -12.77% | ||
| 6 months | +3.23% | ||
| Current year | -12.88% |
| 1 week | 493.64 |  | 539.39 |
| 1 month | 493.64 | | 643.99 |
| Current year | 493.64 | | 643.99 |
| 1 year | 385.46 | | 643.99 |
| 3 years | 385.46 | | 643.99 |
| 5 years | 385.46 | | 672.34 |
| 10 years | 127.65 | | 672.34 |
| Manager | Title | Age | Since |
|---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 58 | 2009-10-14 |
| Director of Finance/CFO | 59 | 2015-07-31 | |
Sebastian Pacios
CTO | Chief Tech/Sci/R&D Officer | - | 2023-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Scott Sperling
BRD | Director/Board Member | 68 | 2006-11-08 |
Marc Casper
CHM | Chairman | 58 | 2020-02-25 |
Tyler Jacks
BRD | Director/Board Member | 65 | 2009-05-25 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -0.48% | 7.43% | 26 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.98% | -7.67% | -5.08% | -9.46% | 190B | |
| +1.51% | -1.42% | -18.42% | +102.30% | 173B | |
| -1.10% | -1.88% | +3.04% | -16.88% | 150B | |
| +0.82% | +0.82% | -29.57% | +60.78% | 111B | |
| +0.61% | +0.32% | -28.57% | -18.53% | 53.87B | |
| -0.75% | -1.21% | -0.42% | -1.82% | 44.03B | |
| +2.78% | -8.48% | +8.40% | +18.06% | 36.79B | |
| +2.15% | +1.59% | -12.87% | +13.30% | 36.61B | |
| +0.74% | -1.33% | -6.58% | -15.15% | 35.58B | |
| -1.19% | -1.80% | -29.04% | -42.42% | 32.52B | |
| Average | +0.46% | -2.68% | -11.91% | +9.02% | 86.27B | |
| Weighted average by Cap. | +0.20% | -2.88% | -11.43% | +21.11% |
| 2025 | 2026 * | |
|---|---|---|
| Net sales | 44.28B 37.35B 34.07B 32.48B 60.35B 4,020B 62.61B 396B 157B 1,935B 166B 163B 6,796B | 46.82B 39.5B 36.03B 34.35B 63.81B 4,251B 66.2B 419B 166B 2,047B 176B 172B 7,186B |
| Net income | 6.72B 5.67B 5.17B 4.93B 9.17B 611B 9.51B 60.13B 23.9B 294B 25.22B 24.7B 1,032B | 7.36B 6.21B 5.66B 5.4B 10.03B 668B 10.41B 65.81B 26.16B 322B 27.6B 27.03B 1,130B |
| Net Debt | 28.29B 23.86B 21.77B 20.75B 38.55B 2,568B 40B 253B 101B 1,236B 106B 104B 4,341B | 25.48B 21.5B 19.61B 18.69B 34.73B 2,314B 36.03B 228B 90.57B 1,114B 95.57B 93.6B 3,911B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-02-13 | 504.82 $ | -0.98% | 3,188,361 |
| 26-02-12 | 509.82 $ | -3.29% | 4,742,103 |
| 26-02-11 | 527.17 $ | -2.34% | 3,367,617 |
| 26-02-10 | 539.80 $ | -1.27% | 2,022,058 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- TMO Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition